Región Metropolitana de Santiago
Este organismo compró $13.486.726.006.527 en 34.361 órdenes de compra , sobre todo en Medicamentos y productos farmacéuticos / Medicamentos anti infecciosos / Medicamentos antivirales y le compró principalmente a Glaxosmithkline Chile Farmaceutica Limitada.
238 meses con data · color por monto (sqrt scale)
| Año | Ene | Feb | Mar | Abr | May | Jun | Jul | Ago | Sep | Oct | Nov | Dic | Total año |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
| $951,1 mil M |
| 2025 | $1,7 B |
| 2024 | $1,8 B |
| 2023 | $1,4 B |
| 2022 | $1,1 B |
| 2021 | $1,2 B |
| 2020 | $1,2 B |
| 2019 | $733,5 mil M |
| 2018 | $526,8 mil M |
| 2017 | $476,6 mil M |
| 2016 | $386,6 mil M |
| 2015 | $399,9 mil M |
| 2014 | $267 mil M |
| 2013 | $274,4 mil M |
| 2012 | $223,1 mil M |
| 2011 | $213,6 mil M |
| 2010 | $190,8 mil M |
| 2009 | $204,7 mil M |
| 2008 | $166,3 mil M |
| 2007 | $196,4 mil M |
| 2006 | $27 mil M |
238 períodos con data
Fuente: Agregaciones mensuales sobre OCs ingeridas
10 contrapartes
Fuente: Tabla top_contrapartes_comprador
| Código | Fecha | Proveedor | Estado | Monto |
|---|---|---|---|---|
| 621-426-SE26 | 06-05-2026 | Cristalia Chile SpA | Aceptada | $283.332.580 |
| 621-375-SE26 | 06-05-2026 | Novofarma Service S.A. | Aceptada | $5.710.712.826 |
| 621-376-SE26 | 06-05-2026 | Ic Global Chile SpA | Aceptada | $239.840.692 |
| 621-463-TD26 | 05-05-2026 | Merck Sharp & Dohme (I.a) Llc,agencia en Chile | Aceptada | $4.480.778.400 |
| 621-359-SE26 | 05-05-2026 | Dfm Pharma SpA | Aceptada | $1.665.171.165 |
| 621-430-SE26 | 05-05-2026 | Blau Farmaceutica Chile SpA | En proceso | $114.990.860 |
| 621-504-SE26 | 05-05-2026 | Emcure Pharma Chile SpA | Aceptada | $1.200.523.284 |
| 621-281-SE26 | 04-05-2026 | Pharma Go SpA | Aceptada | $349.972.812 |
| 621-346-SE26 | 04-05-2026 | Astrazeneca S.A. | Aceptada | $2.056.134.074 |
| 621-501-TD26 | 04-05-2026 | Sociedad de Representacion Importacion y Comercializacion para la Salud y Segur | Aceptada | $190.353.352 |
| 621-364-SE26 | 04-05-2026 | Laboratorio Biosano S.A. | Aceptada | $951.654.900 |
| 621-414-SE26 | 04-05-2026 | Lorenzo Jimenez e Hijo Ltda. | Aceptada | $70.509.285 |
| 621-441-SE26 | 04-05-2026 | Innovative Medicines S.A. Agencia en Chile | Aceptada | $44.232.300 |
| 621-266-SE26 | 04-05-2026 | Industrial y Comercial Baxter de Chile Limitada | Aceptada | $166.811.820 |
| 621-422-SE26 | 04-05-2026 | Farmaceutica Santiago dos SpA | Aceptada | $115.474.173 |
| 621-328-SE26 | 04-05-2026 | Inversiones Sb S.A. | Aceptada | $2.055.981.564 |
| 621-372-SE26 | 04-05-2026 | Laboratorio Sanderson S.A. | Aceptada | $112.812.000 |
| 621-454-SE26 | 04-05-2026 | Farmaceutica Santiago dos SpA | Aceptada | $28.287.252 |
| 621-495-SE26 | 04-05-2026 | Megalabs Chile S.A. | Aceptada | $110.298.720 |
| 621-321-SE26 | 04-05-2026 | Laboratorios Andromaco S.A. | Aceptada | $803.923.689 |
| 621-367-SE26 | 04-05-2026 | Farmedical SpA | Aceptada | $2.393.710.704 |
| 621-139-SE26 | 04-05-2026 | Helios Med Solutions SpA | Aceptada | $79.712.102 |
| 621-274-SE26 | 04-05-2026 | Novofarma Service S.A. | Aceptada | $21.563.694.285 |
| 621-339-SE26 | 04-05-2026 | Productos Farmoquimicos Roche Limitada | Aceptada | $13.407.404.892 |
| 621-424-SE26 | 04-05-2026 | Farmaceutica Santiago dos SpA | Aceptada | $195.486.536 |
| 621-434-SE26 | 04-05-2026 | Ic Global Chile SpA | Aceptada | $251.095.293 |
| 621-453-SE26 | 04-05-2026 | Alembic Pharmaceuticals SpA | Aceptada | $230.987.568 |
| 621-496-SE26 | 04-05-2026 | Aspen Chile S.A. | Aceptada | $442.965.600 |
| 2268-79-AG26 | 30-04-2026 | Importadora Rbc SpA | Aceptada | $296.310 |
| 621-479-SE26 | 29-04-2026 | Novofarma Service S.A. | Aceptada | $121.404.633 |
